Non-alcoholic steatohepatitis: a review of its mechanism, models and medical treatments C Peng, AG Stewart, OL Woodman, RH Ritchie, CX Qin Frontiers in Pharmacology 11, 603926, 2020 | 160 | 2020 |
Understanding the cardioprotective effects of flavonols: discovery of relaxant flavonols without antioxidant activity CX Qin, X Chen, RA Hughes, SJ Williams, OL Woodman Journal of Medicinal Chemistry 51 (6), 1874-1884, 2008 | 117 | 2008 |
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice CX Qin, LT May, R Li, N Cao, S Rosli, M Deo, AE Alexander, D Horlock, ... Nature Communications 8 (1), 14232, 2017 | 112 | 2017 |
Novel role for the AnxA1-Fpr2/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation EY Senchenkova, J Ansari, F Becker, SA Vital, Z Al-Yafeai, ... Circulation 140 (4), 319-335, 2019 | 109 | 2019 |
Enhanced phosphoinositide 3-kinase (p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes RH Ritchie, JE Love, K Huynh, BC Bernardo, DC Henstridge, H Kiriazis, ... Diabetologia 55, 3369-3381, 2012 | 100 | 2012 |
The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms SSC Goh, OL Woodman, S Pepe, AH Cao, C Qin, RH Ritchie Antioxidants & redox signaling 9 (1), 101-113, 2007 | 97 | 2007 |
Cardioprotective potential of annexin-A1 mimetics in myocardial infarction C Qin, YH Yang, L May, X Gao, AG Stewart, Y Tu, OL Woodman, ... Pharmacology & therapeutics 148, 47-65, 2015 | 79 | 2015 |
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review FS Zhang, QZ He, CH Qin, PJ Little, JP Weng, SW Xu Acta Pharmacologica Sinica 43 (9), 2173-2190, 2022 | 70 | 2022 |
Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K (p110α) signaling MJ De Blasio, K Huynh, C Qin, S Rosli, H Kiriazis, A Ayer, N Cemerlang, ... Free Radical Biology and Medicine 87, 137-147, 2015 | 69 | 2015 |
Reperfusion‐induced myocardial dysfunction is prevented by endogenous annexin‐A1 and its N‐terminal‐derived peptide Ac‐ANX‐A12‐26 C Qin, KD Buxton, S Pepe, AH Cao, K Venardos, JE Love, DM Kaye, ... British journal of pharmacology 168 (1), 238-252, 2013 | 65 | 2013 |
Transforming growth factor–β–induced differentiation of airway smooth muscle cells Is inhibited by fibroblast growth Factor–2 M Schuliga, A Javeed, T Harris, Y Xia, C Qin, Z Wang, X Zhang, PVS Lee, ... American journal of respiratory cell and molecular biology 48 (3), 346-353, 2013 | 62 | 2013 |
Distinct contributions of hyperglycemia and high-fat feeding in metabolic syndrome-induced neuroinflammation BJ Wanrooy, KP Kumar, SW Wen, CX Qin, RH Ritchie, CHY Wong Journal of neuroinflammation 15, 1-13, 2018 | 59 | 2018 |
Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications CX Qin, R Sleaby, AJ Davidoff, JR Bell, MJ De Blasio, LM Delbridge, ... Pharmacological Research 116, 45-56, 2017 | 59 | 2017 |
Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes HH Ng, CH Leo, D Prakoso, C Qin, RH Ritchie, LJ Parry Scientific Reports 7 (1), 39604, 2017 | 55 | 2017 |
Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction D Prakoso, MJ De Blasio, C Qin, S Rosli, H Kiriazis, H Qian, XJ Du, ... Clinical science 131 (12), 1345-1360, 2017 | 52 | 2017 |
Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism JA Baltos, EA Vecchio, MA Harris, CX Qin, RH Ritchie, A Christopoulos, ... Biochemical pharmacology 135, 79-89, 2017 | 49 | 2017 |
Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia C Chandramouli, ME Reichelt, CL Curl, U Varma, LA Bienvenu, ... Scientific reports 8 (1), 2346, 2018 | 48 | 2018 |
Therapeutic Potential of Lipoxin A4 in Chronic Inflammation: Focus on Cardiometabolic Disease T Fu, M Mohan, EP Brennan, OL Woodman, C Godson, P Kantharidis, ... ACS pharmacology & translational science 3 (1), 43-55, 2020 | 47 | 2020 |
Current state and future perspective of cardiovascular medicines derived from natural products C Zhao, S Li, J Zhang, Y Huang, L Zhang, F Zhao, X Du, J Hou, T Zhang, ... Pharmacology & Therapeutics 216, 107698, 2020 | 46 | 2020 |
Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo CX Qin, SB Finlayson, A Al-Sharea, M Tate, MJ De Blasio, M Deo, S Rosli, ... Scientific reports 7 (1), 16615, 2017 | 41 | 2017 |